UZEDY (risperidone) extended-release injectable suspension for subcutaneous use is indicated for use every one or two months for the treatment of schizophrenia in adults
The new line features advanced isolator technology to deliver enhanced sterility assurance, throughput and operational precision
Liraglutide Injection, 18 mg/3 mL (6 mg/mL) Single-Patient-Use Prefilled Pen is bioequivalent to Victoza Injection, 18 mg/3 mL (6 mg/mL) of Novo Nordisk
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
Corning and SGD Pharma formed JV in June 2023 to expand pharmaceutical manufacturing in India
No post-injection Delirium/Sedation Syndrome (PDSS) observed through 56 weeks
Keytruda Qlex is the first and only subcutaneously administered immune checkpoint inhibitor that can be given by a health care provider in as little as one minute
Wegovy achieved significant weight loss with one in three study participants losing 20% or more body weight
Four FDA-approved products strengthen portfolio and reaffirm commitment to global reach
Subscribe To Our Newsletter & Stay Updated
